The Genomic Cancer Care Alliance — which currently involves founding organizations Fox Chase Cancer Center, Scripps Genomic Medicine, Omicia, El Camino Hospital, and the Translational Genomics Research Institute — plans to launch a pilot study to investigate the ability of whole-genome sequencing to guide treatment for patients who have responded poorly to initial therapy.